The basis of T-cell-mediated immunity to chronic myelogenous leukemia
- 9 December 2002
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 21 (56), 8668-8673
- https://doi.org/10.1038/sj.onc.1206093
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Analysis of the Modulation of Transcriptional Activity in Myelopoiesis and LeukemogenesisMethods, 1999
- Adoptive immunotherapy with donor lymphocyte transfusionsCurrent Opinion in Oncology, 1997
- Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.Journal of Clinical Investigation, 1995
- Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility AntigenScience, 1995
- Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)Clinical and Experimental Immunology, 1995
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3European Journal of Immunology, 1994
- T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)Clinical and Experimental Immunology, 1994
- A new look for the 1990sNature, 1994
- Myeloblastin/Proteinase 3 Belongs to the Set of Negatively Regulated Primary Response Genes Expressed During in Vitro Myeloid DifferentiationBiochemical and Biophysical Research Communications, 1994
- The Phylogeny of Proteinase 3/Myeloblastin, the Autoantigen in Wegener's Granulomatosis, and Myeloperoxidase as Shown by Immunohistochemical Studies on Human Leukemic Cell LinesClinical Immunology and Immunopathology, 1994